Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial

1. Hauschild, A.
2. Grob, J.-J.
3. Demidov, L.V.
4. Jouary, T.
5. Gutzmer, R.
6. Millward, M.
7. Rutkowski, P.
8. Blank, C.U.
9. Miller Jr., W.H.
10. Kaempgen, E.
11. Martín-Algarra, S.
12. Karaszewska, B.
13. Mauch, C.
14. Chiarion-Sileni, V.
15. Martin, A.-M.
16. Swann, S.
17. Haney, P.
18. Mirakhur, B.
19. Guckert, M.E.
20. Goodman, V.
21. Chapman, P.B.